Pay in 4 interest-free payments of $56.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
developing therapeutic interventions
71 / / Raloxifene 4'-O-β-D-Glucuronide / Raloxifene 4' Glucuronide
This compound provides a lactose (Galβ1-4Glc) building block for glycoconjugate synthesis and the construction of probes for galactose-recognizing proteins
C17H30N4O11 / 466
PE134010: β-GalNAc-PEG3-Azide label-new developing therapeutic interventionsC14H26N4O9 378. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with an azide handle through a hydrophilic PEG3 spacer. The terminal azide couples to alkynes via copper catalyzed azide alkyne cycloaddition (CuAAC) or to DBCO and related strained alkynes via copper free click chemistry, forming stable 1,2,3 triazole linkages. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
US$ 180.00
US$ 450.56
